1Wakimoto H,Aoyagi M,Nakayama T,et al.Prognostic significance of Ki-67 labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas[].Cancer.1996
2Wakaguchi H,Fujimaki T,Matsurro A,et al.Postoperative residual tumor growth of meningioma can be predicted by MIB-1[].Immunohistochemistry.1999
3Knosp E,Kitz K,Perneczky A.Proliferation activity in pitritary adenomas: measurement by monoclonal antibody Ki-67[].Neurosurgery.1989
同被引文献34
1Orme SM, McnaUy R J, Cartwright RA, et al. Mortality and cancer inci- dence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group. J Clin Endocrinol Metab, 1998,83 : 2730- 2734.
2Nomikos P, Buchfelder M, Fahlbusch R. The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical ' cure'. Eur J Endocrinol,2005 ,152 :379-387.
3van der Lely A J, Muller A, Janssen JA, et al. Control of tumor size and disease activity during cotreatment with octreotide and the growth hor- mone receptor antagonist pegvisomant in an acromegalic patient. J Clin Endocrinol Metab,2001,86:478 -481.
4Buchfelder M, Weigel D, Droste M, et al. Pituitary tumor size in acro- megaly during pegvisomant treatment:experience from MR re-evalua- tions of the German Pegvisomant Observational Study. Eur J Endocri- nol.2009.161:27-35.
5Scholzen T,Gerdes J. The Ki-67 protein:from the known and the un- known. J Cell Physiol,2000 ,182 :311-322.
6Turley H, Comley M, Houlbrook S, et al. The distribution and expres- sion of the two isoforms of DNA topoisomerase II in normal and neo- plastic human tissues. Br J Cancer, 1997,75 : 1340-1346.
7Fahlbusch R,Honegger J, Buchfelder M. Acromegaly-the place of the neurosurgeon. Metabolism, 1996,45 : 65 -66.
8Lucas T, Astorga R, Catala M. Preoperative lanreotide treatment for GH-secreting pituitary adenomas:effect on tumour volume and predic- tive factors of significant tumour shrinkage. Clin Endocrinol ( Oxf), 2003,58:471-481.
9Vieira JO Jr, Cukiert A, Liberman B, et al. Evaluation of magnetic resonance imaging criteria for cavernous sinus invasion in patients with pituitary adenomas: logistic regression analysis and correlation with surgical findings [ J ]. Surgical Neurology, 2006,65 (2) : 130- 135.
10Ciric I, Mikhael M, Stafford T, et al. Transsphenoidal microsurgery of pituitary macroade- nomas with long-term follow-up results [ J ]. Neurosurg , 1983,59 ( 3 ) :395 -401.
